We previously identified a rare ERBB3 germline variant that co-segregated with disease in a pedigree with familial erythroid myelodysplastic syndrome/acute myeloid leukemia (MDS/AML), implicating this gene family in predisposition to blood cancers [30]. This evidence concerns the gene ERBB3 and myelodysplastic syndrome.